1. Home
  2. VRA vs KZIA Comparison

VRA vs KZIA Comparison

Compare VRA & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$3.26

Market Cap

117.4M

ML Signal

HOLD

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

HOLD

Current Price

$13.55

Market Cap

100.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
KZIA
Founded
1982
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.4M
100.8M
IPO Year
2010
2002

Fundamental Metrics

Financial Performance
Metric
VRA
KZIA
Price
$3.26
$13.55
Analyst Decision
Hold
Strong Buy
Analyst Count
2
4
Target Price
N/A
$19.50
AVG Volume (30 Days)
190.5K
237.0K
Earning Date
06-10-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
20.47
N/A
EPS
N/A
N/A
Revenue
$416,097,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$3.24
52 Week High
$4.39
$17.40

Technical Indicators

Market Signals
Indicator
VRA
KZIA
Relative Strength Index (RSI) 33.22 62.22
Support Level $1.95 $5.71
Resistance Level $3.33 $14.42
Average True Range (ATR) 0.22 1.08
MACD -0.13 -0.09
Stochastic Oscillator 3.42 58.33

Price Performance

Historical Comparison
VRA
KZIA

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, luggage, and travel items, fashion and home accessories, and gifts. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct and Vera Bradley Indirect.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: